Unique tools for researching funds, shares, investment trusts and ETFs
Latest investment articles
Reckitt Benckiser jumps on plans to spin-off drugs business. Worries over stronger Russia sanctions continue to weigh.
Thousands of investors with failed stockbroker Pritchard face a further nine-month wait before getting back their money.
A roundup of trades by professional investors, including Neil Woodford. This time we look at Synairgen, Ashmore, Macfarlane, Wilmington and Acal.
Second quarter US growth figures should show world's biggest economy has bounced back after cold winter.
The Financial Conduct Authority urges consumers to consider the dangers of owning corporate bonds as interest rates start to rise.
Five financial experts debate the pros and cons of selling shares 'short' to make a profit.
David Sandham explains why the spring sell-off in technology equities represents a healthy 'correction' rather than heralding a repeat of the dotcom crash at the start of the century.
RBS delights the City with a fall in bad debts as the UK economy achieves the 'milestone' of growing beyond pre-crisis levels.
And have Diverse Income (DIVI) and Witan (WTAN) become too expensive? A roundup of what analysts are saying about investment trusts.
Our daily roundup of the best analyst commentary on shares, also including GlaxoSmithKline and Mitchells & Butlers.
Martin Currie, the loss-making Edinburgh-based fund manager, has agreed to be bought by US investment giant Legg Mason.
Experts debate what matters most when designing investment portfolios: income or total return?
My Russia investment trust has fallen after a momentous week, but I'm going to hold steady.
B&Q owner falls 7.5% on disappointing sales. FTSE flat as investor caution prevails amid geopolitical tension.
Hugh Young is tilting the Aberdeen Asian Income investment trust away from high yield shares in anticipation of the US ending quantitative easing or money printing.
The US is a hard market to beat. We look at investment trusts in the North America sectors to see which deliver the goods for investors.
Our daily roundup of the best analyst commentary on shares, also including Provident Financial and Poundland.
(Update) Profits warning hits GlaxoSmithKline. FTSE 100 edges higher despite fear of more punitive EU sanctions against Russia.
It has been a busy year for shareholder activism with a number of firms facing investor revolts over executive pay.
Top performing equity income investor's enthusiasm for fund managers and good dividends overcame his distaste for flotations.
Visit Citywire Selection for more of our best investment ideas